Financials
- Market Capitalization 309.38 M
- Employee 87
- Founded N/A
- CEO N/A
- Website www.editasmedicine.com
- Headquarter Delaware, United States
- FIGI BBG005MX5GZ2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.17
Relación precio/flujo de caja
5.69
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3307 | LYEL Lyell Immunopharma, Inc. - Common Stock | 13.40 USD | -6.49% | -14.43% | +0.30% | -44.61% | 312.68 M USD | ||
| 3308 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 4.05 USD | +4.92% | +2.53% | +17.05% | +4.92% | 312.61 M USD | ||
| 3323 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.23 USD | +0.82% | -6.82% | -0.81% | -28.36% | 306.64 M USD | ||
| 3347 | INDP Indaptus Therapeutics, Inc. - Common Stock | 2.63 USD | 0.00% | +1.54% | -30.61% | +38.42% | 297.83 M USD |